Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.670
+0.130 (8.44%)
At close: Mar 16, 2026, 4:00 PM EDT
1.640
-0.030 (-1.80%)
After-hours: Mar 16, 2026, 4:58 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $103.05 million as of March 16, 2026. Its market cap has increased by 53.35% in one year.
Market Cap
103.05M
Enterprise Value
43.06M
1-Year Change
53.35%
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $103.05M, a decrease of -80.32%. That is a compound annual growth rate of -30.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 95.89M | 33.91% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seer, Inc. | 102.12M |
| Gossamer Bio | 101.17M |
| Q32 Bio | 99.77M |
| Genelux | 98.93M |
| TuHURA Biosciences | 97.39M |
| Fortress Biotech | 96.22M |
| Biomea Fusion | 96.16M |
| Anixa Biosciences | 94.88M |